Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency
Nicholas Hernandez, Isabelle Melki, Huie Jing, Tanwir Habib, Susie S Y Huang, Jeffrey Danielson, Tomasz Kula, Scott Drutman, Serkan Belkaya, Vimel Rattina, Lazaro Lorenzo-Diaz, Anais Boulai, Yoann Rose, Naoki Kitabayashi, Mathieu P Rodero, Cecile Dumaine, Stéphane Blanche, Marie-Noëlle Lebras, Man Chun Leung, Lisa Sara Mathew, Bertrand Boisson, Shen-Ying Zhang, Stephanie Boisson-Dupuis, Silvia Giliani, Damien Chaussabel, Luigi D Notarangelo, Stephen J Elledge, Michael J Ciancanelli, Laurent Abel, Qian Zhang, Nico Marr, Yanick J Crow, Helen C Su, Jean-Laurent Casanova, Nicholas Hernandez, Isabelle Melki, Huie Jing, Tanwir Habib, Susie S Y Huang, Jeffrey Danielson, Tomasz Kula, Scott Drutman, Serkan Belkaya, Vimel Rattina, Lazaro Lorenzo-Diaz, Anais Boulai, Yoann Rose, Naoki Kitabayashi, Mathieu P Rodero, Cecile Dumaine, Stéphane Blanche, Marie-Noëlle Lebras, Man Chun Leung, Lisa Sara Mathew, Bertrand Boisson, Shen-Ying Zhang, Stephanie Boisson-Dupuis, Silvia Giliani, Damien Chaussabel, Luigi D Notarangelo, Stephen J Elledge, Michael J Ciancanelli, Laurent Abel, Qian Zhang, Nico Marr, Yanick J Crow, Helen C Su, Jean-Laurent Casanova
Abstract
Life-threatening pulmonary influenza can be caused by inborn errors of type I and III IFN immunity. We report a 5-yr-old child with severe pulmonary influenza at 2 yr. She is homozygous for a loss-of-function IRF9 allele. Her cells activate gamma-activated factor (GAF) STAT1 homodimers but not IFN-stimulated gene factor 3 (ISGF3) trimers (STAT1/STAT2/IRF9) in response to IFN-α2b. The transcriptome induced by IFN-α2b in the patient's cells is much narrower than that of control cells; however, induction of a subset of IFN-stimulated gene transcripts remains detectable. In vitro, the patient's cells do not control three respiratory viruses, influenza A virus (IAV), parainfluenza virus (PIV), and respiratory syncytial virus (RSV). These phenotypes are rescued by wild-type IRF9, whereas silencing IRF9 expression in control cells increases viral replication. However, the child has controlled various common viruses in vivo, including respiratory viruses other than IAV. Our findings show that human IRF9- and ISGF3-dependent type I and III IFN responsive pathways are essential for controlling IAV.
© 2018 Hernandez et al.
Figures
References
- Abdul-Sater A.A., Majoros A., Plumlee C.R., Perry S., Gu A.D., Lee C., Shresta S., Decker T., and Schindler C.. 2015. Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs. J. Immunol. 195:210–216. 10.4049/jimmunol.1401139
- Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., Kondrashov A.S., and Sunyaev S.R.. 2010. A method and server for predicting damaging missense mutations. Nat. Methods. 7:248–249. 10.1038/nmeth0410-248
- Anders S., Pyl P.T., and Huber W.. 2015. HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 31:166–169. 10.1093/bioinformatics/btu638
- Andrews S.2010. FastQC: a quality control tool for high throughput sequence data. Available at: .
- Arimoto K.I., Löchte S., Stoner S.A., Burkart C., Zhang Y., Miyauchi S., Wilmes S., Fan J.B., Heinisch J.J., Li Z., et al. . 2017. STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling. Nat. Struct. Mol. Biol. 24:279–289. 10.1038/nsmb.3378
- Asgari S., Schlapbach L.J., Anchisi S., Hammer C., Bartha I., Junier T., Mottet-Osman G., Posfay-Barbe K.M., Longchamp D., Stocker M., et al. . 2017. Severe viral respiratory infections in children with IFIH1 loss-of-function mutations. Proc. Natl. Acad. Sci. USA. 114:8342–8347. 10.1073/pnas.1704259114
- Asselin-Paturel C., Brizard G., Chemin K., Boonstra A., O’Garra A., Vicari A., and Trinchieri G.. 2005. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J. Exp. Med. 201:1157–1167. 10.1084/jem.20041930
- Begue B., Verdier J., Rieux-Laucat F., Goulet O., Morali A., Canioni D., Hugot J.P., Daussy C., Verkarre V., Pigneur B., et al. . 2011. Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease. Am. J. Gastroenterol. 106:1544–1555. 10.1038/ajg.2011.112
- Belkadi A., Pedergnana V., Cobat A., Itan Y., Vincent Q.B., Abhyankar A., Shang L., El Baghdadi J., Bousfiha A., Alcais A., et al. Exome/Array Consortium . 2016. Whole-exome sequencing to analyze population structure, parental inbreeding, and familial linkage. Proc. Natl. Acad. Sci. USA. 113:6713–6718. 10.1073/pnas.1606460113
- Boisson B., Laplantine E., Prando C., Giliani S., Israelsson E., Xu Z., Abhyankar A., Israël L., Trevejo-Nunez G., Bogunovic D., et al. . 2012. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat. Immunol. 13:1178–1186. 10.1038/ni.2457
- Boisson-Dupuis S., Kong X.F., Okada S., Cypowyj S., Puel A., Abel L., and Casanova J.L.. 2012. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr. Opin. Immunol. 24:364–378. 10.1016/j.coi.2012.04.011
- Bousfiha A., Jeddane L., Picard C., Ailal F., Bobby Gaspar H., Al-Herz W., Chatila T., Crow Y.J., Cunningham-Rundles C., Etzioni A., et al. . 2018. The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies. J. Clin. Immunol. 38:129–143. 10.1007/s10875-017-0465-8
- Burns C., Cheung A., Stark Z., Choo S., Downie L., White S., Conyers R., and Cole T.. 2016. A novel presentation of homozygous loss-of-function STAT-1 mutation in an infant with hyperinflammation-A case report and review of the literature. J. Allergy Clin. Immunol. Pract. 4:777–779. 10.1016/j.jaip.2016.02.015
- Casanova J.-L. 2015a Human genetic basis of interindividual variability in the course of infection. Proc. Natl. Acad. Sci. USA. 112:E7118–E7127.
- Casanova J.-L. 2015b Severe infectious diseases of childhood as monogenic inborn errors of immunity. Proc. Natl. Acad. Sci. USA. 112:E7128–E7137.
- Casanova J.L., Conley M.E., Seligman S.J., Abel L., and Notarangelo L.D.. 2014. Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J. Exp. Med. 211:2137–2149. 10.1084/jem.20140520
- Centers for Disease Control and Prevention 2013. FluView: Influenza Associated Hospitalization Surveillance Network. Available at: .
- Chapgier A., Boisson-Dupuis S., Jouanguy E., Vogt G., Feinberg J., Prochnicka-Chalufour A., Casrouge A., Yang K., Soudais C., Fieschi C., et al. . 2006. Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet. 2:e131 10.1371/journal.pgen.0020131
- Ciancanelli M.J., Huang S.X.L., Luthra P., Garner H., Itan Y., Volpi S., Lafaille F.G., Trouillet C., Schmolke M., Albrecht R.A., et al. . 2015. Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science. 348:448–453. 10.1126/science.aaa1578
- Ciancanelli M.J., Abel L., Zhang S.-Y., and Casanova J.-L.. 2016. Host genetics of severe influenza: from mouse Mx1 to human IRF7. Curr. Opin. Immunol. 38:109–120. 10.1016/j.coi.2015.12.002
- Coccia E.M., Severa M., Giacomini E., Monneron D., Remoli M.E., Julkunen I., Cella M., Lande R., and Uzé G.. 2004. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 34:796–805. 10.1002/eji.200324610
- Collin M., Dickinson R., and Bigley V.. 2015. Haematopoietic and immune defects associated with GATA2 mutation. Br. J. Haematol. 169:173–187. 10.1111/bjh.13317
- Darnell J.E. Jr., Kerr I.M., and Stark G.R.. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1415–1421. 10.1126/science.8197455
- Dawood F.S., Kamimoto L., D’Mello T.A., Reingold A., Gershman K., Meek J., Arnold K.E., Farley M., Ryan P., Lynfield R., et al. Emerging Infections Program Network . 2011. Children with asthma hospitalized with seasonal or pandemic influenza, 2003-2009. Pediatrics. 128:e27–e32. 10.1542/peds.2010-3343
- de Weerd N.A., Vivian J.P., Nguyen T.K., Mangan N.E., Gould J.A., Braniff S.J., Zaker-Tabrizi L., Fung K.Y., Forster S.C., Beddoe T., et al. . 2013. Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1. Nat. Immunol. 14:901–907. 10.1038/ni.2667
- Dobin A., Davis C.A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., and Gingeras T.R.. 2013. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 29:15–21. 10.1093/bioinformatics/bts635
- Duncan C.J., Mohamad S.M., Young D.F., Skelton A.J., Leahy T.R., Munday D.C., Butler K.M., Morfopoulou S., Brown J.R., Hubank M., et al. . 2015. Human IFNAR2 deficiency: Lessons for antiviral immunity. Sci. Transl. Med. 7:307ra154 10.1126/scitranslmed.aac4227
- Eletto D., Burns S.O., Angulo I., Plagnol V., Gilmour K.C., Henriquez F., Curtis J., Gaspar M., Nowak K., Daza-Cajigal V., et al. . 2016. Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection. Nat. Commun. 7:13992 10.1038/ncomms13992
- Engelhardt K.R., and Grimbacher B.. 2014. IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms. Curr. Top. Microbiol. Immunol. 380:1–18.
- Fu X.Y., Kessler D.S., Veals S.A., Levy D.E., and Darnell J.E. Jr. 1990. ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. Proc. Natl. Acad. Sci. USA. 87:8555–8559. 10.1073/pnas.87.21.8555
- Glocker E.O., Kotlarz D., Boztug K., Gertz E.M., Schäffer A.A., Noyan F., Perro M., Diestelhorst J., Allroth A., Murugan D., et al. . 2009. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361:2033–2045. 10.1056/NEJMoa0907206
- Hahm B., Trifilo M.J., Zuniga E.I., and Oldstone M.B.. 2005. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity. 22:247–257. 10.1016/j.immuni.2005.01.005
- Hambleton S., Goodbourn S., Young D.F., Dickinson P., Mohamad S.M.B., Valappil M., McGovern N., Cant A.J., Hackett S.J., Ghazal P., et al. . 2013. STAT2 deficiency and susceptibility to viral illness in humans. Proc. Natl. Acad. Sci. USA. 110:3053–3058. 10.1073/pnas.1220098110
- Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., and Taniguchi T.. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 434:772–777. 10.1038/nature03464
- Hoyos-Bachiloglu R., Chou J., Sodroski C.N., Beano A., Bainter W., Angelova M., Al Idrissi E., Habazi M.K., Alghamdi H.A., Almanjomi F., et al. . 2017. A digenic human immunodeficiency characterized by IFNAR1 and IFNGR2 mutations. J. Clin. Invest. 127:4415–4420. 10.1172/JCI93486
- Itan Y., Zhang S.Y., Vogt G., Abhyankar A., Herman M., Nitschke P., Fried D., Quintana-Murci L., Abel L., and Casanova J.L.. 2013. The human gene connectome as a map of short cuts for morbid allele discovery. Proc. Natl. Acad. Sci. USA. 110:5558–5563. 10.1073/pnas.1218167110
- Itan Y., Shang L., Boisson B., Patin E., Bolze A., Moncada-Vélez M., Scott E., Ciancanelli M.J., Lafaille F.G., Markle J.G., et al. . 2015. The human gene damage index as a gene-level approach to prioritizing exome variants. Proc. Natl. Acad. Sci. USA. 112:13615–13620. 10.1073/pnas.1518646112
- Itan Y., Shang L., Boisson B., Ciancanelli M.J., Markle J.G., Martinez-Barricarte R., Scott E., Shah I., Stenson P.D., Gleeson J., et al. . 2016. The mutation significance cutoff: gene-level thresholds for variant predictions. Nat. Methods. 13:109–110. 10.1038/nmeth.3739
- Iwasaki A., and Pillai P.S.. 2014. Innate immunity to influenza virus infection. Nat. Rev. Immunol. 14:315–328. 10.1038/nri3665
- Jaworska J., Gravel A., and Flamand L.. 2010. Divergent susceptibilities of human herpesvirus 6 variants to type I interferons. Proc. Natl. Acad. Sci. USA. 107:8369–8374. 10.1073/pnas.0909951107
- John J., McKendry R., Pellegrini S., Flavell D., Kerr I.M., and Stark G.R.. 1991. Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons. Mol. Cell. Biol. 11:4189–4195. 10.1128/MCB.11.8.4189
- Johnson K.D., Hsu A.P., Ryu M.J., Wang J., Gao X., Boyer M.E., Liu Y., Lee Y., Calvo K.R., Keles S., et al. . 2012. Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. J. Clin. Invest. 122:3692–3704. 10.1172/JCI61623
- Kaminski M.M., Ohnemus A., Cornitescu M., and Staeheli P.. 2012. Plasmacytoid dendritic cells and Toll-like receptor 7-dependent signalling promote efficient protection of mice against highly virulent influenza A virus. J. Gen. Virol. 93:555–559. 10.1099/vir.0.039065-0
- Kimura T., Kadokawa Y., Harada H., Matsumoto M., Sato M., Kashiwazaki Y., Tarutani M., Tan R.S., Takasugi T., Matsuyama T., et al. . 1996. Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells. 1:115–124. 10.1046/j.1365-2443.1996.08008.x
- Kircher M., Witten D.M., Jain P., O’Roak B.J., Cooper G.M., and Shendure J.. 2014. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46:310–315. 10.1038/ng.2892
- Koerner I., Kochs G., Kalinke U., Weiss S., and Staeheli P.. 2007. Protective role of beta interferon in host defense against influenza A virus. J. Virol. 81:2025–2030. 10.1128/JVI.01718-06
- Kreins A.Y., Ciancanelli M.J., Okada S., Kong X.F., Ramírez-Alejo N., Kilic S.S., El Baghdadi J., Nonoyama S., Mahdaviani S.A., Ailal F., et al. . 2015. Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome. J. Exp. Med. 212:1641–1662. 10.1084/jem.20140280
- Lamborn I.T., Jing H., Zhang Y., Drutman S.B., Abbott J.K., Munir S., Bade S., Murdock H.M., Santos C.P., Brock L.G., et al. . 2017. Recurrent rhinovirus infections in a child with inherited MDA5 deficiency. J. Exp. Med. 214:1949–1972. 10.1084/jem.20161759
- Lauterbach H., Bathke B., Gilles S., Traidl-Hoffmann C., Luber C.A., Fejer G., Freudenberg M.A., Davey G.M., Vremec D., Kallies A., et al. . 2010. Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. J. Exp. Med. 207:2703–2717. 10.1084/jem.20092720
- Li H., and Durbin R.. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 25:1754–1760. 10.1093/bioinformatics/btp324
- Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., and Durbin R.. 1000 Genome Project Data Processing Subgroup . 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 25:2078–2079. 10.1093/bioinformatics/btp352
- Li W., Hofer M.J., Songkhunawej P., Jung S.R., Hancock D., Denyer G., and Campbell I.L.. 2017. Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9. J. Biol. Chem. 292:5845–5859. 10.1074/jbc.M116.756510
- Lou Y.J., Pan X.R., Jia P.M., Li D., Xiao S., Zhang Z.L., Chen S.J., Chen Z., and Tong J.H.. 2009. IRF-9/STAT2 [corrected] functional interaction drives retinoic acid-induced gene G expression independently of STAT1. Cancer Res. 69:3673–3680. 10.1158/0008-5472.CAN-08-4922
- McKenna A., Hanna M., Banks E., Sivachenko A., Cibulskis K., Kernytsky A., Garimella K., Altshuler D., Gabriel S., Daly M., and DePristo M.A.. 2010. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20:1297–1303. 10.1101/gr.107524.110
- McQuillan R., Leutenegger A.L., Abdel-Rahman R., Franklin C.S., Pericic M., Barac-Lauc L., Smolej-Narancic N., Janicijevic B., Polasek O., Tenesa A., et al. . 2008. Runs of homozygosity in European populations. Am. J. Hum. Genet. 83:359–372. 10.1016/j.ajhg.2008.08.007
- Moens L., Van Eyck L., Jochmans D., Mitera T., Frans G., Bossuyt X., Matthys P., Neyts J., Ciancanelli M., Zhang S.Y., et al. . 2017. A novel kindred with inherited STAT2 deficiency and severe viral illness. J. Allergy Clin. Immunol. 139:1995–1997.e9. 10.1016/j.jaci.2016.10.033
- Mordstein M., Kochs G., Dumoutier L., Renauld J.C., Paludan S.R., Klucher K., and Staeheli P.. 2008. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 4:e1000151 10.1371/journal.ppat.1000151
- Mostafavi S., Yoshida H., Moodley D., LeBoité H., Rothamel K., Raj T., Ye C.J., Chevrier N., Zhang S.Y., Feng T., et al. Immunological Genome Project Consortium . 2016. Parsing the Interferon Transcriptional Network and Its Disease Associations. Cell. 164:564–578. 10.1016/j.cell.2015.12.032
- Ng P.C., and Henikoff S.. 2001. Predicting deleterious amino acid substitutions. Genome Res. 11:863–874. 10.1101/gr.176601
- Ning S., Pagano J.S., and Barber G.N.. 2011. IRF7: activation, regulation, modification and function. Genes Immun. 12:399–414. 10.1038/gene.2011.21
- O’Donnell L.A., Conway S., Rose R.W., Nicolas E., Slifker M., Balachandran S., and Rall G.F.. 2012. STAT1-independent control of a neurotropic measles virus challenge in primary neurons and infected mice. J. Immunol. 188:1915–1923. 10.4049/jimmunol.1101356
- Onodera K., Fujiwara T., Onishi Y., Itoh-Nakadai A., Okitsu Y., Fukuhara N., Ishizawa K., Shimizu R., Yamamoto M., and Harigae H.. 2016. GATA2 regulates dendritic cell differentiation. Blood. 128:508–518. 10.1182/blood-2016-02-698118
- Osterlund P.I., Pietilä T.E., Veckman V., Kotenko S.V., and Julkunen I.. 2007. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J. Immunol. 179:3434–3442. 10.4049/jimmunol.179.6.3434
- Palese P., and Shaw M.L.. 2007. Fields Virology. Lippincott Williams & Wilkins, Philadephia.
- Pasquet M., Bellanné-Chantelot C., Tavitian S., Prade N., Beaupain B., Larochelle O., Petit A., Rohrlich P., Ferrand C., Van Den Neste E., et al. . 2013. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood. 121:822–829. 10.1182/blood-2012-08-447367
- Picard C., Bobby Gaspar H., Al-Herz W., Bousfiha A., Casanova J.L., Chatila T., Crow Y.J., Cunningham-Rundles C., Etzioni A., Franco J.L., et al. . 2018. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. J. Clin. Immunol. 38:96–128. 10.1007/s10875-017-0464-9
- Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., and Sham P.C.. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81:559–575. 10.1086/519795
- Rengachari S., Groiss S., Devos J.M., Caron E., Grandvaux N., and Panne D.. 2018. Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function. Proc. Natl. Acad. Sci. USA. 115:E601–E609. 10.1073/pnas.1718426115
- Rusinova I., Forster S., Yu S., Kannan A., Masse M., Cumming H., Chapman R., and Hertzog P.J.. 2013. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 41(Database issue, D1):D1040–D1046. 10.1093/nar/gks1215
- Sato M., Hata N., Asagiri M., Nakaya T., Taniguchi T., and Tanaka N.. 1998. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett. 441:106–110. 10.1016/S0014-5793(98)01514-2
- Shahni R., Cale C.M., Anderson G., Osellame L.D., Hambleton S., Jacques T.S., Wedatilake Y., Taanman J.W., Chan E., Qasim W., et al. . 2015. Signal transducer and activator of transcription 2 deficiency is a novel disorder of mitochondrial fission. Brain. 138:2834–2846. 10.1093/brain/awv182
- Shieh W.J., Blau D.M., Denison A.M., Deleon-Carnes M., Adem P., Bhatnagar J., Sumner J., Liu L., Patel M., Batten B., et al. . 2010. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am. J. Pathol. 177:166–175.
- Short K.R., Kroeze E.J.B.V., Fouchier R.A.M., and Kuiken T.. 2014. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect. Dis. 14:57–69. 10.1016/S1473-3099(13)70286-X
- Sole-Violan J., Sologuren I., Betancor E., Zhang S., Pérez C., Herrera-Ramos E., Martínez-Saavedra M., López-Rodriguez M., Pestano J., Ruiz-Hernández J., et al. . 2013. Lethal influenza virus A H1N1 infection in two relatives with autosomal dominant GATA-2 deficiency. Crit. Care. 17(Suppl 2):15 10.1186/cc11953
- Sologuren I., Martinez-Saavedra M.T., Sole-Violan J., de Borges de Oliveira E. Jr., Betancor E., Casas I., Oleaga-Quintas C., Martinez-Gallo M., Zhang S.Y., Pestano J., et al. . 2018. Lethal Influenza in Two Related Adults with Inherited GATA2 Deficiency. J. Clin. Immunol.
- Staeheli P., Grob R., Meier E., Sutcliffe J.G., and Haller O.. 1988. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol. Cell. Biol. 8:4518–4523. 10.1128/MCB.8.10.4518
- Stark G.R., and Darnell J.E. Jr. 2012. The JAK-STAT pathway at twenty. Immunity. 36:503–514. 10.1016/j.immuni.2012.03.013
- Stoletzki N., and Eyre-Walker A.. 2011. Estimation of the neutrality index. Mol. Biol. Evol. 28:63–70. 10.1093/molbev/msq249
- Tang X., Gao J.S., Guan Y.J., McLane K.E., Yuan Z.L., Ramratnam B., and Chin Y.E.. 2007. Acetylation-dependent signal transduction for type I interferon receptor. Cell. 131:93–105. 10.1016/j.cell.2007.07.034
- Taniguchi T., Ogasawara K., Takaoka A., and Tanaka N.. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623–655. 10.1146/annurev.immunol.19.1.623
- Taubenberger J.K., and Morens D.M.. 2006. 1918 Influenza: the mother of all pandemics. Emerg. Infect. Dis. 12:15–22. 10.3201/eid1209.05-0979
- Taubenberger J.K., and Morens D.M.. 2008. The pathology of influenza virus infections. Annu. Rev. Pathol. 3:499–522. 10.1146/annurev.pathmechdis.3.121806.154316
- Team R.D.C. 2008. R: A language and environment for statistical computing. R Foundation for Statistical Comuting, Vienna, Austria.
- Veals S.A., Schindler C., Leonard D., Fu X.Y., Aebersold R., Darnell J.E. Jr., and Levy D.E.. 1992. Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol. Cell. Biol. 12:3315–3324. 10.1128/MCB.12.8.3315
- Veals S.A., Santa Maria T., and Levy D.E.. 1993. Two domains of ISGF3 gamma that mediate protein-DNA and protein-protein interactions during transcription factor assembly contribute to DNA-binding specificity. Mol. Cell. Biol. 13:196–206. 10.1128/MCB.13.1.196
- Warde-Farley D., Donaldson S.L., Comes O., Zuberi K., Badrawi R., Chao P., Franz M., Grouios C., Kazi F., Lopes C.T., et al. . 2010. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 38(Web Server issue, suppl_2):W214-20 10.1093/nar/gkq537
- Wilk E., Pandey A.K., Leist S.R., Hatesuer B., Preusse M., Pommerenke C., Wang J., and Schughart K.. 2015. RNAseq expression analysis of resistant and susceptible mice after influenza A virus infection identifies novel genes associated with virus replication and important for host resistance to infection. BMC Genomics. 16:655 10.1186/s12864-015-1867-8
- Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza, Bautista E., Chotpitayasunondh T., Gao Z., Harper S.A., Shaw M., Uyeki T.M., Zaki S.R., Hayden F.G., Hui D.S., Kettner J.D., et al. . 2010. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N. Engl. J. Med. 362:1708–1719.
- Xu G.J., Kula T., Xu Q., Li M.Z., Vernon S.D., Ndung’u T., Ruxrungtham K., Sanchez J., Brander C., Chung R.T., et al. . 2015. Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome. Science. 348:aaa0698 10.1126/science.aaa0698
- Zaki M., Thoenes M., Kawalia A., Nürnberg P., Kaiser R., Heller R., and Bolz H.J.. 2017. Recurrent and Prolonged Infections in a Child with a Homozygous IFIH1 Nonsense Mutation. Front. Genet. 8:130.
- Zhang C., Cai Z., Kim Y.C., Kumar R., Yuan F., Shi P.Y., Kao C., and Luo G.. 2005. Stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymerase. J. Virol. 79:8687–8697. 10.1128/JVI.79.14.8687-8697.2005
- Zhang S.Y., Jouanguy E., Ugolini S., Smahi A., Elain G., Romero P., Segal D., Sancho-Shimizu V., Lorenzo L., Puel A., et al. . 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science. 317:1522–1527. 10.1126/science.1139522
Source: PubMed